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Topical Ginger Treatment With a Compress  
or Patch for Osteoarthritis Symptoms
Tessa Therkleson, PhD, RN
RATO Health Ltd, New Zealand
School of Nursing, Edith Cowan University, Perth, Australia
Aim: This article is a report of a study evaluating changes in health status before and after topical gin-
ger treatment for adults with moderate to severe osteoarthritis. Method: In 2011, 20 adults with 
chronic osteoarthritis were randomly assigned to one of two groups for 7 consecutive days of topical 
ginger treatment by trained nurses: Group 1 received a manually prepared ginger compress and Group 
2 a standardized ginger patch. Participants had the option to continue self-treatment using the ginger 
patch for a further 24 weeks. A brief arthritis health questionnaire was completed weekly for 3 weeks 
and 4 weekly for 24 weeks. Results: The mean scores for Group 1 and Group 2 show a notable decline 
following 1-week topical ginger treatment; scores in pain, fatigue, global effect, and functional status 
reduced by 48%, 49%, 40%, and 31%, respectively, whereas health satisfaction improved from 80% dis-
satisfied to 70% satisfied. Scores for all participants in all five domains progressively reduced over the 
following 24 weeks of self-treatment. Conclusion: Topical ginger treatment has the potential to relieve 
symptoms, improve the overall health, and increase independence of people with chronic osteoarthritis.
Keywords: older adults; alternative therapies; chronic pain; herbal remedies; chronic conditions
Osteoarthritis (OA) is a chronic degenerative 
disease of the articular cartilage primarily affecting 
the hips, knees, and hands that subsequently 
accounts for the majority of joint replacements and 
musculoskeletal pain and disability in Western soci-
ety (Zhang, Moskowitz, et al., 2008). OA is most 
prevalent in those over 65 years, especially females, 
and accounts for more problems while climbing 
stairs and walking as well as lost efficacy at work 
than any other disease (Bijlsma, Berenbaum, & 
Lafeber, 2011). The chronic pain and disability 
caused by OA often leads to compounding health 
issues, such as chronic tiredness, inability to cope 
with life, anxiety, and depression that need to be 
considered in the overall management (Lane et al., 
2011). Research shows that people with OA choose 
to use more complementary alternative medicines 
than for any other chronic health condition 
(Henderson, 2004; Lapane, Sands, Yang, McAlindon, 
& Eaton, 2012), and there is a preference for topical 
applications (Callahan et al., 2009; Herman, Craig, 
& Caspi, 2005). Ginger has been identified as hav-
ing a role as an antiarthritic agent through its 
antithrombotic and anti-inflammatory effects (Ali, 
Blunden, Tanira, & Nemmar, 2008; Terry, Posadzki, 
Watson, & Ernst, 2011), and there is limited research 
showing beneficial effects from topical ginger appli-
cations in OA (Therkleson, 2010a).
The purpose of this study is to advance research 
on the association between topical ginger treatment 
using either a traditional manually prepared ginger 
compress or a standardized ginger patch and the 
relief of OA symptoms. Although internal ginger 
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extract has been found effective in managing sub-
jective experiences of pain and functional impair-
ment in OA (Fajardo & Di Cesare, 2005; Terry et 
al., 2011), the high doses required often cause 
gastrointestinal disturbances (Marcus & Suarez-
Almazor, 2001; Wigler, Grotto, Caspi, & Yaron, 
2003). Topical ginger avoids these potential nega-
tive effects, and when applied over the mid-lumbar 
region, qualitative studies suggest a positive effect 
on mobility, mood, energy levels, and overall sense 
of well-being (Therkleson, 2010b; Therkleson & 
Sherwood, 2004). Topical ginger applied as ginger 
compresses to the kidney region is part of the prac-
tice of anthroposophic nursing for patients with 
chronic inflammatory conditions such as arthritis. 
In 1923, anthroposophic nursing was founded in 
the Ita Wegman Clinic in Arlesheim, Switzerland, 
and today there are more than 25 specialist hospi-
tals and clinics throughout Europe, with nursing 
practice summarized in Fingado (2011, 2012). 
Anthroposophic nurses are registered practicing 
nurses, who have completed postgraduate educa-
tion to advance their understanding of the anthro-
posophical perspective in health and illness as 
introduced in Steiner and Wegman (1925/1967). 
Since 1996 in New Zealand, there have been 
courses educating registered practicing nurses in 
anthroposophic nursing theory and practice 
(Therkleson, 2007).
This study is the first known quantitative study 
of topical ginger treatments for people with OA. In 
early 2013, a database search for “topical ginger” 
was done on a wide range of sources: Pub Med 
Central, Elsevier-Science Direct, Medline, 
Cumulative Index to Nursing and Allied Health 
Literature (CINHL), Web of Science, and Blackwell 
Synergy. Ginger patches were developed to enhance 
the reliability of results and to ensure that replica-
tion was possible in the home, with the minimum of 
effort from participants.
Method and Materials
Aim
The aim of this study is twofold: (a) to evaluate 
a standardized ginger patch alongside that of a tradi-
tional manually prepared ginger compress over 7 
consecutive days in a clinic by using a simple, brief 
arthritis questionnaire and (2) to evaluate the use of 
the ginger patch at home for over 24 weeks using a 
simple, brief arthritis questionnaire.
The secondary aims are to
• Evaluate and compare changes in participant 
perception of pain intensity, chronic fatigue, 
global effect of OA, mobility, and overall 
satisfaction with health
• Evaluate participant changes in the use of 
pain medication and/or pain management
• Evaluate the safety of the application of both 
the ginger patch and ginger compress through 
participant and nurse written reports
Design
Part 1. In 2011, a 3-week, open-label, two-group 
study using three brief self-report questionnaires 
(SRQ) was used to evaluate participants’ perceived 
response to topical ginger treatments. Throughout 
the 3 weeks, participants maintained their normal 
established OA management procedures. Routine 
analgesic medication was noted in a daily diary 
alongside a daily pain questionnaire.
Twenty volunteer adults with OA were randomly 
assigned to either Group 1 (compress) or Group 2 
(patch). Randomization was sequential in time as 
participants were recruited at the first interview. 
This is a two-group design with a 1:1 allocation to 
each of the two interventions; Group 1 had 10 
receiving a manually prepared ginger compress, and 
Group 2 had 10 receiving the standardized ginger 
patch. To ensure equal numbers in each group, a 
restricted randomized scheme was used, with a 
block size of 4 (Machin & Fayers, 2010).
The intervention was 7 consecutive days of topi-
cal ginger treatments, given at four medical clinics 
by anthroposophic nurses. Topical ginger treatment 
was the same for all participants and involved lying 
on the back in a quiet, warm space, with a pre-
warmed ginger patch/compress applied to the mid-
lumbar region for 30 minutes, followed by a rest of 
20 minutes. The compress and standardized patch 
each had the equivalent of 1 g dry ground organic 
Zingiber officinale rhizome (ginger) from the same 
certified batch. The compress was prepared prior to 
use by dissolving 10 g of ground ginger in 100 mL 
hot water, soaking a cloth in the mixture and squeez-
ing firmly. The patches were prepared exclusively for 
the study: each comprising a piece of crepe paper 
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and extract with 1 g ginger and purified water. The 
same procedure and protocol for topical ginger com-
press treatments used in a previous qualitative study 
for 10 people with OA was followed (Therkleson, 
2010b). Before and after each treatment, nurses 
monitored participants’ basic physiological measures 
of temperature, pulse, respiration, blood pressure, 
and body weight and the observed and reported 
effects of the intervention. Although there are no 
known risks or side effects to ginger therapy, this 
was an added precaution. The brief Modified Health 
Assessment Questionnaire (MHAQ) was completed 
weekly for the first 3 weeks: 1 week before treat-
ment, 12 hours after treatment, and 1 week after 
treatment.
Part 2. Following the initial 3 weeks, all participants 
were offered the option to continue self-treatment at 
home using the ginger patch only as required for a 
further 24 weeks. The ginger patch was used by all 
participants for self-treatments because it is simple 
to apply, as well as convenient and reliable. The 
ginger compress is awkward and difficult to prepare 
in a consistent and reliable manner by patients. 
Participants were educated in the use of the ginger 
patch, with adequate supplies of patches available 
from the clinics. The MHAQ was completed four 
times a week for 24 weeks either in person or by 
telephone, depending on participant availability.
This study has appropriate state ethical approval 
in New Zealand. All participants gave their informed, 
signed consent to be part of the study, and all iden-
tification is anonymous.
Sample
The sample comprised 20 consenting Caucasian 
adults diagnosed with chronic symptomatic OA in 
any site for at least 1 year. Advertisements went to 
community groups and medical centers in two New 
Zealand cities. OA was confirmed by Kellgren and 
Lawrence X-ray Grades 2 and 3; health assessment 
was based on clinical diagnosis and completion of 
the short arthritis assessment scale (SAS; Wolfe, 
Michaud, Kahler, & Omar, 2004). The SAS asks 
four simple questions relating to pain, functional 
status, and global effect of OA in the previous week, 
each on a 10-point Likert-type scale, with 0 for no 
problem and 10 for very severe problem. No partici-
pant was accepted with a pain score less than 5/10 
or a total score less than 18/40. The health assess-
ment excluded those with a joint replacement of the 
affected joint, rheumatoid arthritis, fibromyalgia, 
cancer, and other serious health conditions; those 
who were not naive to the therapy; and those having 
corticosteroids and/or anticoagulants in the past 12 
weeks. This same selection method proved effective 
in a previous ginger compress qualitative study 
(Therkleson, 2010a).
Data Collection
This study uses three brief SRQ that have been 
found reliable and valid in rheumatology: (a) SAS, 
(b) modified MHAQ, and (c) daily pain question-
naire for 21 days.
The SAS (Wolfe, Michaud, Kahler, et al., 2004) 
was used solely to confirm selection of participants. 
The SAS is designed specifically to assess OA symp-
toms quickly and effectively in the clinical and 
research setting (Wolfe, Michaud, Kahler, et al., 
2004).
The MHAQ was completed 7 days before topical 
ginger treatments, within 12 hours after the treat-
ments, 7 days later, and 4 weekly for 24 weeks. The 
MHAQ was prepared by the National Data Bank for 
Rheumatic Diseases to be used as a simple, brief 
questionnaire in the clinical and research setting. It 
was effective in the prospective Arthritis Outcomes 
Study led by Wolfe, Pincus, Thompson, and Doyle 
(2003). The MHAQ is one page long and asks 14 
simple questions relating to the past week: (a) 3 
independent questions on pain, fatigue, and global 
effect each recorded on a 10-cm visual analog scale 
(VAS); (b) 10 questions on functional status recorded 
on the Health Assessment Questionnaire–II 
(HAQ-II; Wolfe, Michaud, & Pincus, 2004); and (c) 
one question on health satisfaction recorded on a 
categorical scale. The HAQ-II has 10 items and was 
developed as a brief and simplified version of the 
original HAQ (Bruce & Fries, 2003a, 2003b) disa-
bility index used in rheumatology.
The daily pain scale was completed for 21 con-
secutive days (7 days before therapy, 7 days during 
therapy, and 7 days after therapy) on a 10-cm VAS, 
with 0 for no problem and 10 for very severe prob-
lem. The 10-cm VAS is recognized in rheumatology 
as the most robust quantitative pain measure (Sokka, 
2003; Tuulikki, 2003). Changes in pain relief medi-
cation were also recorded daily below the scale. The 
additional data relating to medication provide 
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increased understanding of the changes in OA sta-
tus before and after topical ginger therapy.
Participant total mean scores are given for the 
three questions on a VAS and the HAQ-II, with pro-
portions for the one categorical variable. MHAQ 
total scoring was out of 3, with each of the questions 
on the 10-cm VAS and the 10 questions on the 
HAQ-II totaling 3. The 21-day pain scale was scored 
from 0 to 3, with 0 being no problem and 3 being a 
severe problem. The HAQ-II has 10 items with each 
scored from 0 to 3: 0 to 1 is mild to moderate disa-
bility, 1 to 2 is moderate to severe disability, and 2 to 
3 is severe to very severe disability. The total HAQ-II 
score is divided by 10, resulting in 3 being the high-
est score possible in functional status. By maintain-
ing consistency in the scoring of each question, it 
was possible to compare the final scores of the 
groups.
Results
The sample size is small limiting formal statisti-
cal testing; nonetheless means, standard deviation 
(SD), standard error bars, and % differences are 
given. Excel software was used to analyze the data.
The sample comprised 20 consenting Caucasian 
adults with varying characteristics and OA status at 
baseline. Participants, mean age 64 years, 80% 
female, had a mean pain score at baseline of 6.8, 
with 10 being the most extreme pain; mean pain 
score for Group 1 was 6/10 and for Group 2 7/10. 
Most participants had OA of the hips and/or knees 
(17/20, 85%), whereas the remainder in the hands, 
shoulder, cervical, and lumbar regions for a mean of 
8 years, SD of 6. Sixteen participants were from 
participating medical practices and 4 from the com-
munity. The SAS was quick and simple to complete, 
easily scored and effective in confirming selection. 
Total SAS scores ranged from 36/40 to 18/40, with 
a mean score of 26/40 and SD of 4.5; mean of 
Group 1 was 6/10 and Group 2 was 7/10.
The MHAQ was well received by participants; it 
was brief and easily completed. The 21-day pain 
VAS gave added confidence in scoring pain on the 
MHAQ.
Part 1: The mean MHAQ scores for Groups 1 
and 2 show a notable decline after topical 
ginger treatment; Group 1 was 1.75/3 at 
baseline and 1.15/3 one week after therapy, 
whereas Group 2 was 1.85/3 at baseline and 
0.95/3 one week after therapy (see Figure 1).
Part 2: Following the week of topical ginger 
compress treatments in the clinics, Group 1 is 
identified as Group 1a and is now using only 
ginger patches as is Group 2. Figure 1 shows the 
mean MHAQ scores, excluding health 
satisfaction status for Groups 1a and 2, 4 weekly 
for 24 weeks on a line plot with error bars.
The mean MHAQ scores indicate a positive 
response after 1 week treatment on the VAS in pain, 
fatigue, and global effect, with percentage responses 
of 48%, 49%, and 40%, respectively, and on the 
HAQ-II for functional status 31%. Tubach et al. 
(2005) state that a meaningful clinical improvement 
in knee and hip OA for pain on the 10-cm VAS is 
40.8% to 32% and global effect on the 10-cm VAS 
39% to 32%, whereas functional status on Western 
Ontario and McMaster Universities Osteoarthritis 
Index function is 26% to 21%. Figures 2 to 5 show 
box plots for Group 1/1a and Group 2 with standard 
error bars for each of the four domains of the 
MHAQ—pain, fatigue, functional status, and global 
effect—over the 27-week study. At baseline, the 
median in all four domains varied from 2.4 to 1.2/3, 
and after 27 weeks, it was below 0.4/3 in all domains.
The final question for health satisfaction status 
on a categorical scale indicates a positive shift, with 
80% dissatisfied 7 days before therapy, 70% satisfied 
7 days after therapy, and 82% satisfied 24 weeks 
after self-treatment (see Table 1).
During the initial 3-week study, the daily mean 
pain scores compared favorably with the weekly 
MHAQ mean pain scores, with a SD of 0.01. The 
baseline mean pain score for all participants was 
2.2/3, then 7 days after therapy the mean was 
0.95/3. All participants in the sample registered a 
reduction in pain no matter what happened (medi-
cation taken, activity level, and degree of severity of 
symptoms). Medication for pain relief decreased 
during the study. At commencement, 6 participants 
took no pain relief, and 14 took conventional anal-
gesics as required. After 7 days of ginger therapy, 5 
of the 14 participants continued their usual medica-
tion regime, whereas 9 stopped all forms of analge-
sia; then 4 weeks later, 11 participants reported 
requiring no further pain relief as previously 
required. After 4 weeks, 78% of those previously tak-
ing analgesia were no longer requiring this addi-
tional support.
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Figure 1. Mean MHAQ Scores for Groups 1/1a and 2
Note: MHAQ = Modified Health Assessment Questionnaire.
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Figure 2. MHAQ Mean Pain Scores for Groups 1/1a and 2
Note: MHAQ = Modified Health Assessment Questionnaire.
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Figure 3. MHAQ Mean Fatigue Scores for Groups 1/1a and 2
Note: MHAQ = Modified Health Assessment Questionnaire.
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The 20 participants were motivated to be 100% 
compliant in every aspect of the study, and there 
were no reported adverse effects from nurses or par-
ticipants. One participant did not continue self-
treatment due to comorbidities that compromised 
the ability to maintain a balanced perspective, when 
completing the SRQ.
Limitations
Although this study shows a positive response to 
topical ginger therapy, the small numbers do not 
allow for clinical significance. There are a number 
of limitations because this is
• A study with no specific hypothesis.
• A small sample based in one culture with 
treatments given in four selected medical 
practices. A larger participant sample from a 
wider pool would avoid biases and support 
statistically based generalizations.
• A sample with a variation of OA sites. A study 
centering on a single OA site would provide a 
more even cohort.
Figure 5. MHAQ Mean Global Effect Scores for Groups 1/1a and 2
Note: MHAQ = Modified Health Assessment Questionnaire.
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Table 1. MHAQ Health Satisfaction, Groups 1/1a and 2
7 Days Before 
Therapy
7 Days After 
Therapy
12 Weeks 
After Therapy
24 Weeks 
After Therapy
Very satisfied 0% 20% 26% 39%
Somewhat satisfied 5% 50% 58% 44%
Neither satisfied nor dissatisfied 15% 5% 5% 6%
Somewhat dissatisfied 45% 20% 11% 11%
Very dissatisfied 35% 5% 0% 0%
Note: MHAQ = Modified Health Assessment Questionnaire.
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• An open-label, two-group design, with no 
control for observational biases, natural 
history, or maturation.
• A treatment that includes rest, warmth, and 
relationship to the nurse and the researcher.
Discussion
This study extends previous qualitative research 
on topical ginger treatments that reported the warm-
ing and relaxing experience of topical ginger com-
presses (Therkleson, 2010b; Therkleson & Sherwood, 
2004). The same procedure is used as with previous 
research of the ginger compress, while the manually 
prepared ginger compress is evaluated alongside a 
standardized ginger patch by using simple, brief 
SRQs. Results show the ginger patch worked as well 
as the compress, irrespective of medication taken, 
level of activity, and degree of severity of symptoms. 
Previous research for people with OA has shown the 
significance of relaxation and warmth physically and 
emotionally (Baird & Sands, 2006; Cantarini et al., 
2007; Chen et al., 2010; Morone & Greco, 2007) 
and that chronic pain leads to difficulties with cogni-
tive functioning and psychological well-being 
(Dohrenbusch, Buchanan, Lipka, & Ott, 2008; 
Mouchnino et al., 2005; Smith & Zautra, 2008). 
Results from this study are consistent with this 
research; participants prior to topical ginger treat-
ments suffered extreme chronic pain, fatigue, exhaus-
tion, and dissatisfaction with their health status.
Pain on movement is the primary symptom of OA, 
and pain is considered the most important category of 
body functionality in the International Classification 
of Function, Disability and Health (Stucki et al., 
2002). This study showed a significant shift in pain 
symptoms by using the 10-cm VAS pain scoring daily 
for 21 days, and the MHAQ 7 days before and 7 days 
after therapy. Considering that a 30% reduction in 
pain on a VAS is meaningful, this study’s results are 
notable (Kelly, 2001). Participants reported a reduc-
tion in chronic fatigue, dissatisfaction with health 
status, and overall global effect of OA, as well as pain 
and functional status. Topical ginger treatments are 
reportedly effective in managing chronic respiratory 
and metabolic problems as well as anxiety and depres-
sive disorders (Fingado, 2012) and have no known 
side effects, which improves its profile over the use of 
nonsteroidal anti-inflammatory drugs, COX-2 inhibi-
tors, and analgesics for people with OA. Topical ginger 
is not found to have the negative effects of internal 
ginger administration for people with OA (Marcus & 
Suarez-Almazor, 2001) or the peripheral anesthesia 
caused by topical capsaicin (Dedov et al., 2002).
Caution must be used in considering these 
results as chronic pain is the one condition in which 
a statistically significant effect is observed when a 
placebo is used for patients with OA. Systematic 
reviews on the reported placebo effect in rand-
omized control trials for patients with OA found that 
the placebo is very effective in treating self-report 
pain, stiffness, and functionality in patients with OA 
(Zeidler, 2011; Zhang, Robertson, Jones, Dieppe, & 
Doherty, 2008). Although this is an important factor, 
it needs to be considered alongside the results of 
this study, where participants reported a significant 
reduction in chronic fatigue, dissatisfaction with 
health status, overall global effect of OA, as well as 
analgesia, pain, and functional status.
In this study, the topical application of ginger was 
distal to the OA site, which suggests systemic absorp-
tion. The active ingredients of ginger (gingerols and 
shogaols) have a molecular weight of 150 to 190 Da, 
a lipophilicity log P range 3.5, and moderate solubil-
ity in water and oil, which allows good potential for 
skin penetration (Jolad et al., 2004; Minghetti et al., 
2007). Studies on human skin using ginger extract 
show evidence of absorption. Ginger extract was 
absorbed in human epithelial tissue and inhibited 
COX-2 (Tjendraputra, Tran, Liu-Brennan, Roufogalis, 
& Duke, 2001), and Mingetti et al. (2007) found that 
a gingerol extract on a plaster was absorbed transder-
mally through human epidermis as well as having an 
effective anti-inflammatory response on mouse skin. 
Mingetti et al. conclude there would likely be an 
anti-inflammatory effect with the transdermal deliv-
ery of ginger.
Topical ginger treatments offer a novel approach 
to managing the debilitating symptoms of OA. The 
mechanism of action is likely a combination of 
increased warmth and relaxation, systemic absorp-
tion of the ginger, and the placebo effect resulting 
from receiving the intervention along with the 
opportunity to self-treat in the home.
Conclusion
Topical ginger on the mid-lumbar region is a sim-
ple treatment that has the potential to manage the 
complex range of symptoms experienced by people 
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with OA. Manually prepared compresses and stand-
ardized patches applied for 7 consecutive days 
decreased symptoms of pain and disability for 20 
adults with OA. This positive response continued 
over the following 24 weeks, with self-treatment. 
Topical ginger treatments were found to improve the 
subdimensions of quality of life scores of physical 
function, pain, and health satisfaction and overall 
global effect of OA. The noninvasive nature of topi-
cal ginger avoids the risks of conventional medica-
tion and surgery and has the potential to delay and 
possibly negate the use of these more invasive treat-
ments. This study advances previous qualitative 
studies on topical ginger for OA by using brief and 
simple SRQs. Although a small sample, the positive 
response warrants further controlled research with a 
larger and more even cohort.
The domain of topical ginger is those people 
with OA for whom existing treatments are unsatis-
factory due to personal preference, complex comor-
bidities, and/or existing medication regimes. The 
wide range of symptoms, ongoing debilitating effect, 
and absence of a cure means people with OA are 
often prepared to consider a range of options, 
including alternative approaches. Topical ginger 
treatments are a convenient, simple, and economi-
cal option that needs to be considered in the care of 
the aged with OA.
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